Form 4 Tracker
Robin Kramer

Chief Financial Officer; Director · 3 filings · Latest: Mar 9, 2026

Armata Pharmaceuticals, Inc.
BIOGEN INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BIIB
Robin KramerChief Financial OfficerFeb 6, 2026
Option Exercise
$0.005,00312,534.748